help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandell, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandell, J. W.
(American Journal of Pathology. 2003;163:1687-1698.)
© 2003 American Society for Investigative Pathology


Review

Phosphorylation State-Specific Antibodies

Applications in Investigative and Diagnostic Pathology

James W. Mandell

From the Department of Pathology (Neuropathology) and Neuroscience Graduate Program, University of Virginia, Charlottesville, Virginia

Abstract

Until recently, the investigation of protein phosphorylation was limited to biochemical studies of enzyme activities in homogenized tissues. The availability of hundreds of phosphorylation state-specific antibodies (PSSAs) now makes possible the study of protein phosphorylation in situ, and is opening many exciting opportunities in investigative and diagnostic pathology. This review illustrates the power of PSSAs, especially in immunohistochemical applications to human disease and animal models. Technical considerations, including antibody specificity and lability of phosphoepitopes, are covered, along with potential pitfalls, illustrated by a case study. In the arena of oncology, PSSAs may prove especially valuable in directly demonstrating the efficacy of chemotherapies targeted at protein kinase cascades. Novel applications of PSSAs are also beginning to reveal molecular mechanisms of inflammatory, degenerative, and toxin-induced diseases.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Miyamoto, N. Oshiro, K.-i. Yoshino, A. Nakashima, S. Eguchi, M. Takahashi, Y. Ono, U. Kikkawa, and K. Yonezawa
AMP-activated Protein Kinase Phosphorylates Golgi-specific Brefeldin A Resistance Factor 1 at Thr1337 to Induce Disassembly of Golgi Apparatus
J. Biol. Chem., February 15, 2008; 283(7): 4430 - 4438.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Mottok, C. Renne, K. Willenbrock, M.-L. Hansmann, and A. Brauninger
Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6
Blood, November 1, 2007; 110(9): 3387 - 3390.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. M. Khan, T. A. Ponzio, G. Sanchez-Watts, B. G. Stanley, G. I. Hatton, and A. G. Watts
Catecholaminergic Control of Mitogen-Activated Protein Kinase Signaling in Paraventricular Neuroendocrine Neurons In Vivo and In Vitro: A Proposed Role during Glycemic Challenges
J. Neurosci., July 4, 2007; 27(27): 7344 - 7360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nyalendo, M. Michaud, E. Beaulieu, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau
Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573: ROLE IN ENDOTHELIAL AND TUMOR CELL MIGRATION
J. Biol. Chem., May 25, 2007; 282(21): 15690 - 15699.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S. Lassmann, I. Schuster, A. Walch, H. Gobel, U. Jutting, F. Makowiec, U. Hopt, and M. Werner
STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation
J. Clin. Pathol., February 1, 2007; 60(2): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Renne, K. Willenbrock, R. Kuppers, M.-L. Hansmann, and A. Brauninger
Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
Blood, May 15, 2005; 105(10): 4051 - 4059.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page

Vet. Pathol., March 1, 2004; 41(2): 201 - 202.
[Full Text] [PDF]


Home page
Toxicol PatholHome page
E. Floyd and T. M. Mcshane
Development and Use of Biomarkers in Oncology Drug Development
Toxicol Pathol, January 1, 2004; 32(1_suppl): 106 - 115.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.